Skip to main content

. 1978 Aug 5;2(6134):403. doi: 10.1136/bmj.2.6134.403

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

A Helgeland, I Hjermann, P Leren, S Enger, I Holme

PMCID: PMC1609028 PMID: 210877

403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970 Nov;11(6):583–595. [PubMed] [Google Scholar]
Helgeland A., Hjermann I., Holme I., Leren P. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. Am J Med. 1978 Jan;64(1):34–38. doi: 10.1016/0002-9343(78)90177-8. [DOI] [PubMed] [Google Scholar]
Helgeland A., Hjermann I., Leren P., Holme I. Possible metabolic side effects of beta-adrenergic blocking drugs. Br Med J. 1978 Apr 1;1(6116):828–828. doi: 10.1136/bmj.1.6116.828. [DOI] [PMC free article] [PubMed] [Google Scholar]
Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
Waal-Manning H. J. Metabolic effects of beta-adrenoreceptor blockers. Drugs. 1976;11(Suppl 1):121–126. doi: 10.2165/00003495-197600111-00027. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES